// App-Quantinova.ai

3582 : Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC): A prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomography (PET), and the RECIST criteria.

Researchers

Presenter

  • Brigette Ma

Principal Investigators

  • Ann Dorothy King

  • LI Leung

  • Herbert H. F. Loong

  • Rosalie Ho

  • Frankie Mo

  • Wing Ming Ho

  • Charles Chan

  • Anthony T. C. Chan

  • Cesar SC Wong

  • Annette Poon

  • Ki Wang

Medical Centers

  • Partner State Key Laboratory of Oncology in South China, Sir Y K Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong

  • State Key Laboratory of Oncology in South China, Sir Y K Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong KongDepartment of Health Technology and Informatics, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Kowloon, Hong KongSir YK Pao Center for Cancer, State Key Laboratory in Oncology in South China, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, Hong Kong

  • Prince of Wales Hospital, Shatin, Hong Kong

  • Department of Imaging and Interventional Radiology, Prince of Wales Hospital, Shatin, Hong Kong

  • Department of Imaging and Interventional Radiology, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China

  • Department of Clinical Oncology, Prince of Wales Hospital, Shatin, Hong Kong

Locations

  • China

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • 18F-fluorodeoxyglucose

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved